CN114504607A - Extraction method of cajanus cajan leaf polyphenol, cajanus cajan leaf polyphenol nanoparticles and application of cajanus cajan leaf polyphenol nanoparticles - Google Patents
Extraction method of cajanus cajan leaf polyphenol, cajanus cajan leaf polyphenol nanoparticles and application of cajanus cajan leaf polyphenol nanoparticles Download PDFInfo
- Publication number
- CN114504607A CN114504607A CN202210192596.4A CN202210192596A CN114504607A CN 114504607 A CN114504607 A CN 114504607A CN 202210192596 A CN202210192596 A CN 202210192596A CN 114504607 A CN114504607 A CN 114504607A
- Authority
- CN
- China
- Prior art keywords
- leaf polyphenol
- cajan leaf
- cajan
- nanoparticles
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 127
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 123
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 101
- 238000000605 extraction Methods 0.000 title claims abstract description 48
- 235000010773 Cajanus indicus Nutrition 0.000 title claims description 21
- 241000220450 Cajanus cajan Species 0.000 title 3
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims abstract description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000007864 aqueous solution Substances 0.000 claims abstract description 26
- 235000013373 food additive Nutrition 0.000 claims abstract description 7
- 239000002778 food additive Substances 0.000 claims abstract description 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 7
- 239000000490 cosmetic additive Substances 0.000 claims abstract description 6
- 239000000725 suspension Substances 0.000 claims description 30
- 238000004108 freeze drying Methods 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- 244000105627 Cajanus indicus Species 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 11
- 238000002390 rotary evaporation Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 7
- 241000220442 Cajanus Species 0.000 claims description 5
- 238000000034 method Methods 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 22
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 230000004663 cell proliferation Effects 0.000 abstract description 6
- 238000005265 energy consumption Methods 0.000 abstract description 5
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 13
- -1 polyphenol compounds Chemical class 0.000 description 10
- 239000000523 sample Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 238000011068 loading method Methods 0.000 description 8
- 229920000858 Cyclodextrin Polymers 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 239000000469 ethanolic extract Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001644 anti-hepatocarcinoma Effects 0.000 description 3
- 230000009702 cancer cell proliferation Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 238000003760 magnetic stirring Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000272201 Columbiformes Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000122904 Mucuna Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010051548 Burn infection Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 241001247414 Couma Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000012296 anti-solvent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 238000001782 photodegradation Methods 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3562—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a method for extracting cajan leaf polyphenol, cajan leaf polyphenol nanoparticles and application thereof, and relates to the technical field of plant extraction. The method for extracting the cajan leaf polyphenol from the aqueous solution of 2-hydroxypropyl-beta-cyclodextrin is green and environment-friendly, low in energy consumption and cost, high in extraction rate of the cajan leaf polyphenol and equivalent to the extraction effect of 70% ethanol; in addition, the extraction method provided by the invention is simple to operate. The invention also provides the cajan leaf polyphenol nanoparticles obtained by the extraction method, wherein the cajan leaf polyphenol nanoparticles comprise 2-hydroxypropyl-beta-cyclodextrin and cajan leaf polyphenol embedded in the 2-hydroxypropyl-beta-cyclodextrin; the cajan leaf polyphenol nanoparticles have good water solubility, antioxidant activity, antibacterial activity and antitumor cell proliferation activity, can be widely applied to pharmaceutical preparations, food additives and cosmetic additives, and have good economic value.
Description
Technical Field
The invention relates to the technical field of plant extraction, and particularly relates to a method for extracting cajan leaf polyphenol, cajan leaf polyphenol nanoparticles and application of the cajan leaf polyphenol nanoparticles.
Background
Pigeons (Cajanus cajan (Linn.) Millsp.) are annual or perennial upright shrubs of the genus Cajanus of the family Dolabean, and are mainly distributed in tropical and subtropical areas, and the pigeons are mainly produced in Yunnan, Hainan, Guangdong, Guangxi, Sichuan and other places in China. The pigeon pea yield ranks sixth in the world bean yield, is also the only edible woody bean crop, has wide application, and can be used as grain, feed, vegetables, food additives and the like. According to records in 'Luchuan herbal medicine', the pigeonpea leaves are neutral and light, have the efficacy of detoxifying and reducing swelling, and are used for treating trauma, burn infection, bedsore, chicken pox, femoral head necrosis, diabetes and other diseases in China.
Modern pharmacological studies show that the pigeon pea leaves contain polyphenol components with good activity, such as flavonoids, stilbenes and the like, and the active components have good effects of resisting oxidation, bacteria and tumors, diminishing inflammation, relieving pain, resisting osteoporosis, protecting heart and brain ischemia injury and the like. In view of these pharmacological actions, cajan leaves have been developed into various pharmaceutical preparations, for example, patent CN200510004897.6 discloses a compound cajan leaf Chinese medicinal preparation, patent CN200510004898.0 discloses a Chinese medicinal preparation prepared from cajan leaf extract for treating bone fracture diseases, patent CN202011331572.x discloses a Chinese medicinal preparation prepared from cajan leaves and other Chinese medicinal materials for treating postmenopausal osteoporosis, and patent CN201010592727.5 discloses a cajan stilbene acid preparation for preventing and treating bacterial infectious diseases. The preparation is prepared by extracting active ingredients from folium Cajani.
Extraction is the key to qualitative, quantitative analysis and development and utilization of active ingredients in plant materials. At present, the active ingredients of the cajan leaves are mainly extracted by an organic solvent extraction method, such as an organic solvent of ethanol or ethyl acetate, or a high-temperature decoction method. The organic solvent has certain toxicity, and poses threats to human health and environment; the high-temperature decoction can destroy the structure of the compound in the pigeon pea leaves, and the energy consumption is high.
Disclosure of Invention
In view of the above, the present invention aims to provide a method for extracting cajan leaf polyphenol, cajan leaf polyphenol nanoparticles, and applications thereof. The extraction method provided by the invention is environment-friendly, low in energy consumption and high in extraction rate of the cajan leaf polyphenol.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a method for extracting cajan leaf polyphenol, which comprises the following steps:
mixing the 2-hydroxypropyl-beta-cyclodextrin aqueous solution and the cajan leaf powder, and performing ultrasonic extraction to obtain an extracting solution;
under the condition of stirring, dropwise adding the extracting solution into absolute ethyl alcohol to obtain a nano-particle suspension;
and sequentially carrying out rotary evaporation and freeze drying on the nanoparticle suspension to obtain the cajan leaf polyphenol nanoparticles.
Preferably, the concentration of the 2-hydroxypropyl-beta-cyclodextrin aqueous solution is 20-60 mg/mL; the ratio of the volume of the 2-hydroxypropyl-beta-cyclodextrin aqueous solution to the mass of the cajan leaf powder is 50mL (1-3 g).
Preferably, the particle size of the cajan leaf powder is 20-60 meshes.
Preferably, the power of ultrasonic extraction is 100-200W, the time is 10-30 min, and the temperature is 20-40 ℃.
Preferably, the stirring speed is 100-300 rpm.
Preferably, the dropping rate is 0.3-0.8 mL/min; the volume ratio of the extracting solution to the absolute ethyl alcohol is 1: 3-1: 5.
Preferably, the temperature of the rotary evaporation is 45-50 ℃, and the pressure is 0-0.1 MPa; the freeze drying is vacuum freeze drying, the temperature of the vacuum freeze drying is-45 to-50 ℃, and the time is 48 to 72 hours.
The invention provides the cajan leaf polyphenol nanoparticles obtained by the extraction method in the technical scheme, and the cajan leaf polyphenol nanoparticles comprise 2-hydroxypropyl-beta-cyclodextrin and cajan leaf polyphenol embedded in the 2-hydroxypropyl-beta-cyclodextrin.
Preferably, the particle size of the cajan leaf polyphenol nanoparticles is 20-300 nm, and the mass content of cajan leaf polyphenol in the cajan leaf polyphenol nanoparticles is 1-3%.
The invention also provides application of the cajan leaf polyphenol nanoparticles in pharmaceutical preparations, food additives and cosmetic additives.
The invention provides a method for extracting cajan leaf polyphenol, which comprises the following steps: mixing the 2-hydroxypropyl-beta-cyclodextrin aqueous solution and the cajan leaf powder, and performing ultrasonic extraction to obtain an extracting solution; under the condition of stirring, dropwise adding the extracting solution into absolute ethyl alcohol to obtain a nano-particle suspension; and sequentially carrying out rotary evaporation and freeze drying on the nanoparticle suspension to obtain the cajan leaf polyphenol nanoparticles. According to the invention, 2-hydroxypropyl-beta-cyclodextrin aqueous solution is used as an extractant of cajan leaf polyphenol, most of cajan leaves are hydrophobic polyphenol compounds, 2-hydroxypropyl-beta-cyclodextrin is hydrophilic in appearance and hydrophobic in inner cavity, and cajan leaf polyphenol compounds can be embedded through the inner cavity, so that extraction of cajan leaf polyphenol is realized. The method for extracting the cajan leaf polyphenol from the aqueous solution of 2-hydroxypropyl-beta-cyclodextrin is green and environment-friendly, low in energy consumption and cost, high in extraction rate of the cajan leaf polyphenol, and equivalent to the extraction effect of 70% ethanol in volume concentration; in addition, the extraction method provided by the invention is simple to operate.
The invention also provides the cajan leaf polyphenol nanoparticles obtained by the extraction method in the technical scheme, wherein the cajan leaf polyphenol nanoparticles comprise 2-hydroxypropyl-beta-cyclodextrin and cajan leaf polyphenol embedded in the 2-hydroxypropyl-beta-cyclodextrin. In the invention, due to the embedding effect of the 2-hydroxypropyl-beta-cyclodextrin, the cajan leaf polyphenol can be prevented from being oxidized, the stability and the biological activity of the cajan leaf polyphenol are effectively maintained, and the cajan leaf polyphenol nanoparticles have good antioxidant activity, antibacterial activity and antitumor cell proliferation activity; in addition, the 2-hydroxypropyl-beta-cyclodextrin has good water solubility, so that the water solubility of the hydrophobic cajan leaf polyphenol can be improved, and the release of the cajan leaf polyphenol in a human body is facilitated; in addition, the cajan leaf polyphenol nanoparticles are in a nanometer level, have a large specific surface area and are favorable for digestion and absorption in the gastrointestinal environment of a human body. The cajanus cajan leaf polyphenol nanoparticles provided by the invention can be widely applied to pharmaceutical preparations, food additives and cosmetic additives, and have good economic value.
Drawings
FIG. 1 is a schematic diagram of a process for extracting polyphenols from cajan leaves according to an embodiment of the present invention;
FIG. 2 is an SEM image of the nanoparticle suspension obtained in example 3;
FIG. 3 is an SEM image of nanoparticles obtained after freeze-drying in example 3;
fig. 4 is a graph showing the particle size distribution of the nanoparticles obtained after freeze-drying in example 3.
Detailed Description
The invention provides a method for extracting cajan leaf polyphenol, which comprises the following steps:
mixing the 2-hydroxypropyl-beta-cyclodextrin aqueous solution and the cajan leaf powder, and performing ultrasonic extraction to obtain an extracting solution;
under the condition of stirring, dropwise adding the extracting solution into absolute ethyl alcohol to obtain a nano-particle suspension;
and sequentially carrying out rotary evaporation and freeze drying on the nanoparticle suspension to obtain the cajan leaf polyphenol nanoparticles.
The invention mixes 2-hydroxypropyl-beta-cyclodextrin aqueous solution and cajan leaf powder for ultrasonic extraction to obtain extract. In the invention, the concentration of the 2-hydroxypropyl-beta-cyclodextrin aqueous solution is preferably 20-60 mg/mL, more preferably 30-50 mg/mL, and further preferably 40 mg/mL; the 2-hydroxypropyl-beta-cyclodextrin aqueous solution is obtained by dissolving 2-hydroxypropyl-beta-cyclodextrin in water, and the water is preferably distilled water. The source of the 2-hydroxypropyl-beta-cyclodextrin is not particularly required in the present invention, and can be obtained by using a commercially available product well known to those skilled in the art or by using a method well known to those skilled in the art. In the invention, the particle size of the cajan leaf powder is preferably 20-60 meshes, more preferably 40 meshes, and the cajan leaf powder with the particle size is preferably obtained by crushing cajan leaves. In the present invention, the ratio of the volume of the 2-hydroxypropyl- β -cyclodextrin aqueous solution to the mass of the cajan leaf powder (i.e., the liquid-solid ratio) is preferably 50mL (1-3) g, more preferably 50mL (1-2) g, and still more preferably 50mL (1 g). In the present invention, the specific operation method of the mixing is preferably: putting the powder of cajan leaves in a closed container, and then adding the aqueous solution of 2-hydroxypropyl-beta-cyclodextrin. In the invention, the power of ultrasonic extraction is preferably 100-200W, more preferably 100-150W, the time is preferably 10-30 min, more preferably 20-30 min, and the temperature is preferably 20-40 ℃, more preferably 30 ℃. After ultrasonic extraction, the invention preferably filters the obtained mixed solution to remove filter residues, and the obtained filtrate is the extracting solution.
Cyclodextrin (CD for short) is a series of cyclic oligosaccharides, and usually contains 6-12D-glucopyranose units, the cavity of the Cyclodextrin is hydrophobic, the exterior of the Cyclodextrin is hydrophilic, the inner diameter of the cavity is related to the number of glucose units of the Cyclodextrin, the number of the glucose units of alpha, beta and gamma-CDs is respectively 6, 7 and 8, and the inner diameter of the Cyclodextrin is respectively 0.57, 0.78 and 0.95 nm. The cyclodextrin can encapsulate a plurality of bioactive components due to a special hydrophobic cavity structure, namely, a guest molecule is complexed with CD to form an inclusion body according to a certain stoichiometric ratio, and the encapsulation effect enables the guest molecule to avoid negative effects such as photodegradation, enzymatic decomposition, spatial rearrangement, racemization, oxidation and even hydrolysis. The water solubility of beta-CD can be improved by forming hydroxypropyl-beta-cyclodextrin (HP-beta-CD) by introducing hydroxypropyl into beta-CD through intramolecular hydrogen bonds due to intramolecular hydrogen bonds formed between hydroxyl groups of beta-cyclodextrin C2 and C3, so that the water solubility of beta-CD is poor, and the 2-hydroxypropyl-beta-cyclodextrin (2-HP-beta-CD) is formed by connecting hydroxypropyl on C2. The 2-hydroxypropyl-beta-cyclodextrin has the characteristics of hydrophilic appearance and hydrophobic inner cavity, can be used as an extractant of the cajan leaf polyphenol, and has good water solubility, so that the water solubility of the hydrophobic cajan leaf polyphenol can be improved.
After the extracting solution is obtained, the extracting solution is dripped into absolute ethyl alcohol under the stirring condition to obtain the nanoparticle suspension. In the invention, the stirring speed is preferably 100-300 rpm, and more preferably 200 rpm; the dripping rate is preferably 0.3-0.8 mL/min, and more preferably 0.5 mL/min; the volume ratio of the extracting solution to the absolute ethyl alcohol is preferably 1: 3-1: 5, and more preferably 1: 4; after the addition, stirring is preferably continued for 30 min. The invention adopts an anti-solvent nano precipitation method to obtain a nano particle suspension.
After the nano-particle suspension is obtained, the nano-particle suspension is sequentially subjected to rotary evaporation and freeze drying to obtain the cajan leaf polyphenol nano-particles. In the invention, the rotary evaporation temperature is preferably 45-50 ℃, and the pressure is preferably 0-0.1 MPa; according to the invention, ethanol in the nanoparticle suspension is removed through the rotary evaporation to obtain the concentrated nanoparticle suspension, and the time of the rotary evaporation is based on the full removal of the ethanol. In the invention, the freeze drying is preferably vacuum freeze drying, the temperature of the vacuum freeze drying is preferably-45 to-50 ℃, and the time is preferably 48 to 72 hours; the vacuum freeze-drying is preferably performed by a vacuum freeze-dryer.
FIG. 1 is a schematic flow chart of the process for extracting polyphenol from cajan leaves according to the embodiment of the invention. The method for extracting the cajan leaf polyphenol from the aqueous solution of 2-hydroxypropyl-beta-cyclodextrin is green and environment-friendly, low in energy consumption and cost, high in extraction rate of the cajan leaf polyphenol, and equivalent to the extraction effect of 70% ethanol in volume concentration; in addition, the extraction method provided by the invention is simple to operate.
The invention provides the cajan leaf polyphenol nanoparticles obtained by the extraction method in the technical scheme, and the cajan leaf polyphenol nanoparticles comprise 2-hydroxypropyl-beta-cyclodextrin and cajan leaf polyphenol embedded in the 2-hydroxypropyl-beta-cyclodextrin. In the invention, the particle size of the cajan leaf polyphenol nanoparticles is preferably 20-300 nm, and the mass content (namely the loading rate) of cajan leaf polyphenol in the cajan leaf polyphenol nanoparticles is preferably 1-3%, and more preferably 1.5-3%. In the invention, due to the embedding effect of the 2-hydroxypropyl-beta-cyclodextrin, the cajan leaf polyphenol can be prevented from being oxidized, the stability and the biological activity of the cajan leaf polyphenol are effectively maintained, and the cajan leaf polyphenol nanoparticles have good antioxidant activity, antibacterial activity and anti-liver cancer cell proliferation activity; in addition, the 2-hydroxypropyl-beta-cyclodextrin has good water solubility, so that the water solubility of the hydrophobic cajan leaf polyphenol can be improved, and the release of the cajan leaf polyphenol in a human body is facilitated.
The invention also provides application of the cajan leaf polyphenol nanoparticles in pharmaceutical preparations, food additives and cosmetic additives. In the invention, the cajanus cajan leaf polyphenol nanoparticles have good anti-tumor cell proliferation activity, especially have good anti-liver cancer cell proliferation activity, and can be used for preparing anti-tumor pharmaceutical preparations; the cajan leaf polyphenol nanoparticles have good antibacterial activity, can be used as a food additive and play a role in keeping food fresh; the cajan leaf polyphenol nanoparticles have good antioxidant activity, can be added into cosmetics as a cosmetic additive, and have the effects of resisting oxidation and preventing aging.
The extraction method of cajan leaf polyphenol, cajan leaf polyphenol nanoparticles and their applications provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
This example prepares cajan leaf polyphenol nanoparticles using 2-hydroxypropyl-beta-cyclodextrin (2-HP-beta-CD) with simultaneous extraction and entrapment. Respectively preparing 2-HP-beta-CD aqueous solutions with the concentrations of 20mg/mL, 40mg/mL and 60mg/mL, and examining the influence of the concentration of the extracting agent on the extraction effect and the embedding effect of the cajan leaf polyphenol so as to select the optimal 2-HP-beta-CD concentration. The method comprises the following steps:
mixing the powder of the cajan leaves crushed to 40 meshes with aqueous solutions of 2-HP-beta-CD with different concentrations, wherein the liquid-solid ratio is 50mL:1g, the ultrasonic time is 30min, the ultrasonic temperature is 30 ℃, and the ultrasonic power is 100W. Filtering out filter residues after extraction is finished, dripping the obtained filtrate into 4 times of volume of absolute ethyl alcohol at a slow dripping speed, stirring by using a magnetic stirrer while titrating, wherein the titration speed is 0.5mL/min, the rotating speed of magnetic stirring is 200rpm, and continuously stirring for 30min after titration is finished to obtain the nanoparticle suspension. The obtained nanoparticle suspension was subjected to ethanol removal at 45 ℃ and-0.1 MPa by a rotary evaporator to obtain a nanoparticle suspension having a volume of 5 mL. Finally, placing the nanoparticle suspension liquid with the compressed volume in a vacuum freeze dryer for freeze drying, wherein the freeze drying conditions are as follows: and (4) the temperature is-45 ℃, and the time is 48 hours, so that the cajan leaf polyphenol nanoparticles are obtained.
The extraction rate, embedding rate, loading rate and water solubility of the cajan leaf polyphenol nanoparticles were measured, and the results are shown in table 1:
TABLE 1 Effect of aqueous 2-HP-beta-CD solutions of different concentrations on the extraction of Mucuna cajan leaf polyphenols and the water solubility of Mucuna cajan leaf polyphenol nanoparticles
In table 1, water solubility refers to the mass (mg) of polyphenol compound that can be dissolved in 1mL of aqueous solution, and the test method is: weighing 1mg of dried cajan leaf polyphenol nanoparticles, calculating and weighing equivalent 2-HP-beta-CD as a blank control according to the loading rate, respectively placing the cajan leaf polyphenol nanoparticles and the 2-HP-beta-CD as the blank control into 1mL of aqueous solution, oscillating for 24h at room temperature, and then determining the polyphenol content in the solution; the extraction rate, the embedding rate and the loading rate are calculated according to the formulas 1 to 3 respectively:
in formulas 1 to 3, the determination method of the mass of the embedded polyphenol and the mass of the extracted polyphenol is as follows:
(1) washing freeze-dried pigeon pea leaf polyphenol nanoparticles twice by using absolute ethyl alcohol, collecting washing liquid, wherein polyphenol in the washing liquid is non-embedded polyphenol (namely free polyphenol), measuring the polyphenol content in the washing liquid, and further calculating the quality of the free polyphenol;
(2) drying the nano particles washed by absolute ethyl alcohol, adding an alcohol: water: acetic acid 50: 42:8 (volume ratio), and carrying out ultrasonic treatment on the obtained mixed solution for 20min to determine the polyphenol content in the mixed solution, namely the embedded polyphenol content, and further calculating the quality of the embedded polyphenol;
(3) the mass of extracted polyphenols, i.e. free polyphenols mass + embedded polyphenols mass, was calculated.
In the steps (1) and (2), the method for measuring the polyphenol content comprises the following steps: sample 40. mu.L, add 1.8mL FC reagent (Fulin reagent), protect from light for 5min, then add 1.2mL 7.5% Na2CO3And keeping away from light for 1.5h, and measuring the light absorption value A at 765 nm. According to the established standard curve: and (3) calculating the polyphenol concentration and further calculating the polyphenol content when Y is 1.0444X +0.0414, wherein Y is the absorbance value and X is the concentration in the standard curve.
As can be seen from the data in Table 1, the higher the concentration of the aqueous solution of 2-HP-beta-CD, the higher the entrapment rate, but the loading rate and the water solubility were decreased, and since the amount of 2-beta-CD added was increased, the amount of extracted cajan leaf polyphenol compounds was also increased, but the increased amount was far from the increased amount of 2-beta-CD. The extraction amount and the cost of 2-HP-beta-CD are comprehensively considered, and the concentration of 2-beta-CD is selected to be 40mg/mL as the optimal selection.
Example 2
This example prepares cajan leaf polyphenol nanoparticles using 2-hydroxypropyl-beta-cyclodextrin (2-HP-beta-CD) with simultaneous extraction and entrapment. Respectively setting the ratio (liquid-solid ratio) of the volume of the 2-HP-beta-CD aqueous solution to the mass of the pigeon pea leaves to be 50mL:1g, 50mL:2g and 50mL:3g, and investigating the influence of the liquid-solid ratio on the extraction effect and the embedding effect to select the optimal liquid-solid ratio, wherein the method comprises the following steps:
mixing the powder of folium Cajani pulverized to 40 meshes with 40mg/mL 2-HP-beta-CD aqueous solution at 30 deg.C for 30min, and ultrasonic power of 100W. Filtering out filter residues after extraction is finished, dripping the obtained filtrate into 4 times of volume of absolute ethyl alcohol at a slow dripping speed, stirring by using a magnetic stirrer while titrating, wherein the titration speed is 0.5mL/min, the rotating speed of magnetic stirring is 200rpm, and continuously stirring for 30min after titration is finished to obtain the nanoparticle suspension. The obtained nanoparticle suspension was subjected to ethanol removal at 45 ℃ and-0.1 MPa by a rotary evaporator to obtain a nanoparticle suspension having a volume of 5 mL. Finally, placing the nanoparticle suspension liquid with the compressed volume in a vacuum freeze dryer for freeze drying, wherein the freeze drying conditions are as follows: and (4) the temperature is-45 ℃, and the time is 48 hours, so that the cajan leaf polyphenol nanoparticles are obtained.
The extraction rate, embedding rate, loading rate and water solubility of the cajan leaf polyphenol nanoparticles were measured, and the results are shown in table 2:
TABLE 2 extraction of polyphenols from cajan leaves with different liquid-solid ratios
As can be seen from Table 2, as the liquid-solid ratio decreased, although the entrapment rate, loading rate, and water solubility all increased, the amount of polyphenol extracted was greatly decreased, and the optimum condition was selected to be 50:1 for a consistent cost of 2-HP- β -CD.
Example 3
This example utilizes 2-hydroxypropyl- β -cyclodextrin (2-HP- β -CD) to simultaneously extract and embed pigeonpea leaf polyphenol nanoparticles as follows:
mixing the powder of folium Cajani pulverized to 40 meshes with 40mg/mL 2-HP-beta-CD aqueous solution at a liquid-solid ratio of 50mL to 1g, and performing ultrasonic treatment at 30 deg.C for 30min with ultrasonic power of 100W. Filtering out filter residues after extraction is finished, dripping the obtained filtrate into 4 times of volume of absolute ethyl alcohol at a slow dripping speed, stirring by using a magnetic stirrer while titrating, wherein the titration speed is 0.5mL/min, the rotating speed of magnetic stirring is 200rpm, and continuously stirring for 30min after titration is finished to obtain the nanoparticle suspension. The obtained nanoparticle suspension was subjected to ethanol removal at 45 ℃ and-0.1 MPa by a rotary evaporator to obtain a nanoparticle suspension having a volume of 5 mL. Finally, placing the nanoparticle suspension liquid with the compressed volume in a vacuum freeze dryer for freeze drying, wherein the freeze drying conditions are as follows: the temperature is-45 ℃, the time is 48h, and the cajan leaf polyphenol nanoparticles are obtained.
FIG. 2 is an SEM image of the nanoparticle suspension (before rotary evaporation), and it can be seen from FIG. 2 that the nanoparticles in the nanoparticle suspension are irregular spherical and have a particle size of 20-300 nm.
Fig. 3 is an SEM image of the nanoparticles obtained after freeze-drying, during which the nanoparticles are aggregated into a flake shape.
FIG. 4 is a graph showing the particle size distribution of the nanoparticles obtained after freeze-drying, wherein the particle size range of the nanoparticles is 20-300 nm.
Comparative example
The comparative example uses ethanol with volume concentration of 70% as an extraction solvent, and adopts an ultrasonic-assisted extraction method to extract the cajan leaf polyphenol, and the method comprises the following steps:
mixing the powder of folium Cajani pulverized to 40 meshes with 70% ethanol solution at a liquid-solid ratio of 50mL:1g, and ultrasonic treating at 30 deg.C for 30min and 100W. Filtering out filter residue after extraction is finished, removing ethanol from the obtained filtrate by using a rotary evaporator under the conditions of 45 ℃ and-0.1 MPa to obtain extract, and dispersing the extract by using 5mL of distilled water. And (3) placing the dispersed extract into a vacuum freeze dryer for freeze drying, wherein the freeze drying conditions are as follows: heating to-45 deg.C for 48 hr to obtain dried folium Cajani ethanol extract.
The nanoparticles obtained in example 3 and the cajan leaf extract obtained in the comparative example were subjected to activity studies, and their DPPH free radical clearance rate, antibacterial activity and anti-hepatoma cell proliferation activity were measured, respectively, by the following methods:
the method for measuring DPPH free radical clearance rate comprises the following steps: mixing 0.1mL of sample solutions with different concentration gradients with 1mL (0.04mg/mL) of DPPH solution, and then adding 1.4mL of absolute ethanol; subsequently, the mixture was kept in the dark for 70 minutes, and the absorbance of the mixture was measured at 517nm, with ascorbic acid as a positive control. The calculation is performed according to equation 4:
in formula 4, ASample (I)Is the ethanol extraction of cajan leaf polyphenol nanoparticles or cajan leavesAbsorbance of the sample; a. theBlank spaceThe absorbance of the blank control is the blank control of the cajan leaf polyphenol nanoparticle sample, the blank control of the cajan leaf polyphenol nanoparticle sample is 2-HP-beta-CD calculated by the loading rate of the cajan leaf polyphenol nanoparticle sample, and the blank control of the cajan leaf ethanol extract sample is ethanol with the volume concentration of 70%.
The determination method of the antibacterial activity comprises the following steps: the antibacterial activity of nanoparticles and ethanol extracts against gram-positive bacteria (bacillus subtilis, staphylococcus aureus) was evaluated by the agar diffusion method. All samples tested were dissolved in DMSO and filtered through a 0.22 μm filter. First, these bacteria were cultured in a nutrient broth at 37 ℃ for 24h and diluted with water to a concentration of 1X 105CFU/mL, 100. mu.L of the bacterial suspension was dispensed onto agar plates (90 mm diameter); subsequently, 20. mu.L of the filtered sample was transferred to an Oxford cup (6mm inner diameter, 8mm outer diameter) on the surface of the agar. Ampicillin and DMSO were used as positive and negative controls, respectively. After the bacteria were cultured at 37 ℃ for 24 hours, the antibacterial activity of the sample was evaluated by measuring the diameter of the zone of inhibition (DIZ).
The method for measuring the anti-hepatoma cell proliferation activity comprises the following steps: the anti-proliferative activity of nanoparticles and ethanol extracts against HepG2 (hepatocellular carcinoma) was evaluated and compared using the MTT (3- (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide) assay. The cells were cultured in a DMEM high-sugar medium, to which 10% fetal bovine serum and 1% penicillin-streptomycin were added, and cultured in a humidified 5% carbon dioxide incubator at 37 ℃. When the cells reached an exponential growth phase (80-90%), they were transferred to 96-well plates and cultured for 24 hours. Samples to be tested were dissolved in DMSO (0.1% v/v) to prepare samples at different concentrations (50-600. mu.g/mL) and added to the cells. After 24 hours, the viability of the cells was measured using MTT, i.e., after the culture was completed, the medium was removed, and the cells were treated with 20. mu.L of MTT reagent (0.5mg/mL) and maintained at 37 ℃ for 4 hours. Next, the generated formazan crystals were dissolved in DMSO; the absorbance was then measured at 570nm with a microplate reader. Control group was DMSO without sample solution. Finally, cell viability was calculated as the percentage of viable cells relative to the control group.
The results are shown in Table 3:
TABLE 3 Couma leaf nanoparticles and ethanol extract extraction yield versus activity comparison results
As can be seen from Table 3, the nanoparticles have stronger antioxidant, antibacterial and anti-hepatoma cell proliferation activities than the ethanol extract.
The embodiment shows that the 2-hydroxypropyl-beta-cyclodextrin aqueous solution is used for extracting the cajan leaf polyphenol, so that the method is green and environment-friendly, the extraction rate of the cajan leaf polyphenol is high, and the extraction method is simple to operate; the obtained cajanus cajan leaf polyphenol nanoparticles have good water solubility, antioxidant activity, antibacterial activity and anti-liver cancer cell proliferation activity.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (10)
1. The extraction method of the cajan leaf polyphenol is characterized by comprising the following steps:
mixing the 2-hydroxypropyl-beta-cyclodextrin aqueous solution and the cajan leaf powder, and performing ultrasonic extraction to obtain an extracting solution;
under the condition of stirring, dropwise adding the extracting solution into absolute ethyl alcohol to obtain a nano-particle suspension;
and sequentially carrying out rotary evaporation and freeze drying on the nanoparticle suspension to obtain the cajan leaf polyphenol nanoparticles.
2. The extraction method according to claim 1, wherein the concentration of the 2-hydroxypropyl- β -cyclodextrin aqueous solution is 20-60 mg/mL; the ratio of the volume of the 2-hydroxypropyl-beta-cyclodextrin aqueous solution to the mass of the cajan leaf powder is 50mL (1-3 g).
3. The extraction method according to claim 1 or 2, wherein the particle size of the cajan leaf powder is 20 to 60 mesh.
4. The extraction method according to claim 1, wherein the power of the ultrasonic extraction is 100-200W, the time is 10-30 min, and the temperature is 20-40 ℃.
5. The extraction method according to claim 1, wherein the stirring speed is 100 to 300 rpm.
6. The extraction method according to claim 1, wherein the dropping rate is 0.3 to 0.8 mL/min; the volume ratio of the extracting solution to the absolute ethyl alcohol is 1: 3-1: 5.
7. The extraction method according to claim 1, wherein the rotary evaporation temperature is 45-50 ℃ and the pressure is 0-0.1 MPa; the freeze drying is vacuum freeze drying, the temperature of the vacuum freeze drying is-45 to-50 ℃, and the time is 48 to 72 hours.
8. The pigeonpea leaf polyphenol nanoparticles obtained by the extraction method of any one of claims 1 to 7, wherein the pigeonpea leaf polyphenol nanoparticles comprise 2-hydroxypropyl-beta-cyclodextrin and pigeonpea leaf polyphenol embedded in the 2-hydroxypropyl-beta-cyclodextrin.
9. The cajanus leaf polyphenol nanoparticle according to claim 8, wherein the particle size of the cajanus leaf polyphenol nanoparticle is 20-300 nm, and the mass content of cajanus leaf polyphenol in the cajanus leaf polyphenol nanoparticle is 1-3%.
10. Use of the pigeonpea leaf polyphenol nanoparticles of claim 8 or 9 in pharmaceutical preparations, food additives and cosmetic additives.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210192596.4A CN114504607A (en) | 2022-03-01 | 2022-03-01 | Extraction method of cajanus cajan leaf polyphenol, cajanus cajan leaf polyphenol nanoparticles and application of cajanus cajan leaf polyphenol nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210192596.4A CN114504607A (en) | 2022-03-01 | 2022-03-01 | Extraction method of cajanus cajan leaf polyphenol, cajanus cajan leaf polyphenol nanoparticles and application of cajanus cajan leaf polyphenol nanoparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114504607A true CN114504607A (en) | 2022-05-17 |
Family
ID=81554697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210192596.4A Pending CN114504607A (en) | 2022-03-01 | 2022-03-01 | Extraction method of cajanus cajan leaf polyphenol, cajanus cajan leaf polyphenol nanoparticles and application of cajanus cajan leaf polyphenol nanoparticles |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114504607A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399716A (en) * | 2015-10-31 | 2016-03-16 | 周俊良 | Method for extracting quercetin from sophora flower bud by using cyclodextrin |
CN109007834A (en) * | 2018-08-31 | 2018-12-18 | 华南理工大学 | A kind of Fructus psidii guajavae immaturus leaf extract cyclodextrin inclusion compound and the preparation method and application thereof |
CN113303473A (en) * | 2021-06-10 | 2021-08-27 | 石河子大学 | Preparation method of apple polyphenol-hydroxypropyl-beta-cyclodextrin inclusion compound |
-
2022
- 2022-03-01 CN CN202210192596.4A patent/CN114504607A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399716A (en) * | 2015-10-31 | 2016-03-16 | 周俊良 | Method for extracting quercetin from sophora flower bud by using cyclodextrin |
CN109007834A (en) * | 2018-08-31 | 2018-12-18 | 华南理工大学 | A kind of Fructus psidii guajavae immaturus leaf extract cyclodextrin inclusion compound and the preparation method and application thereof |
CN113303473A (en) * | 2021-06-10 | 2021-08-27 | 石河子大学 | Preparation method of apple polyphenol-hydroxypropyl-beta-cyclodextrin inclusion compound |
Non-Patent Citations (3)
Title |
---|
朱兴一等: "响应面法优化β-环糊精辅助提取茶多酚的工艺", 《江苏农业科学》 * |
李里特: "《粮食加工新技术 中日食品新技术研讨会论文集》", 31 January 2001 * |
王周利等: "响应面法优化β-环糊精提取葡萄叶白藜芦醇工艺", 《食品科学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
CN113234552B (en) | Hop polysaccharide nano particle and preparation method and application thereof | |
DE102013011026A1 (en) | Composition of a food additive | |
Chainpure et al. | A study of carica papaya concerning it's ancient and Traditional uses-recent advances and modern Applications for improving the milk secretion in Lactating womens | |
CN112316008A (en) | Preparation method of cherry soluble antioxidant dietary fiber/quercetin nano preparation | |
CN113797261A (en) | Preparation method of camellia flower/leaf extract | |
Ali et al. | Phytogenic-mediated silver nanoparticles using Persicaria hydropiper extracts and its catalytic activity against multidrug resistant bacteria | |
CN102000133B (en) | Preparation method of traditional Chinese medicine anti-oxidation preparation | |
Jiamboonsri et al. | Photoassisted synthesis of silver nanoparticles using riceberry rice extract and their antibacterial application | |
KR20190112498A (en) | Whole Ginseng Composition Using Ginseng Roots, Leaves and Berries and Method of Preparing the Same | |
KR101676292B1 (en) | Cosmetic composition comprising an mixed extract of tangle, okra and yam and manufacturing method thereof | |
CN114504607A (en) | Extraction method of cajanus cajan leaf polyphenol, cajanus cajan leaf polyphenol nanoparticles and application of cajanus cajan leaf polyphenol nanoparticles | |
KR20110134015A (en) | Stabilizing method for glabridin | |
KR101143363B1 (en) | The preparing method of Centella asiatica nanoparticle using chitosan, the product, and the food containing the product | |
CN113925081A (en) | Natural plant anticorrosion composition, preparation method and application thereof | |
Subha et al. | Silver Nanoparticles Impregnat-ed Nanocollagen as Scaffold for Soft Tissue Repair-Synthesis, Characterization, and | |
KR102192760B1 (en) | Methods for the manufacturing of water-soluble propolis powder and use thereof | |
CN113318023B (en) | Bougainvillea spectabilis extract and antioxidant blush based on the same | |
JP3128727B2 (en) | Active oxygen scavenger | |
Wu et al. | Synergetic effects and inhibition mechanisms of the polysaccharide‐selenium nanoparticle complex on human hepatocarcinoma cells proliferation | |
CN115368334B (en) | Method for improving extraction efficiency of total flavonoids of bamboo leaves | |
CN114848548B (en) | Peach blossom extract-fullerene compound and preparation method and application thereof | |
CN110358566B (en) | Preparation method and application of peony seed shell wood vinegar and carrier thereof | |
Adekanmi et al. | Assessment of Proximate Composition and Phytochemical Properties of Bitter Leaf (Vernonia Amygdalina) and Water Leaf (Talinum Triangular) | |
CN109985075B (en) | Ginkgo leaf extract injection and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220517 |